Company Overview
NOVOCURE LTD
NVCRRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
655M
2025 FY
Net Income
-136M
2025 FY
Shares Outstanding
111M
2025 FY
EPS
-1.22USD
2025 FY
Company Information
SIC Code
3841
CIK Code
1645113
Exchange
Nasdaq
Location
JE